AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 1 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $291,000 | -91.9% | 8,442 | -92.2% | 0.00% | -100.0% |
| Q4 2019 | $3,600,000 | +252.9% | 107,551 | +119.5% | 0.00% | +300.0% |
| Q2 2019 | $1,020,000 | -6.8% | 49,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $1,095,000 | +14.2% | 49,000 | +22.1% | 0.00% | 0.0% |
| Q4 2018 | $959,000 | -56.1% | 40,141 | -49.8% | 0.00% | -66.7% |
| Q3 2018 | $2,184,000 | +68.9% | 80,000 | +66.4% | 0.00% | +50.0% |
| Q2 2018 | $1,293,000 | +2294.4% | 48,072 | +2727.8% | 0.00% | – |
| Q1 2018 | $54,000 | -73.3% | 1,700 | -68.1% | 0.00% | – |
| Q4 2017 | $202,000 | – | 5,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|